Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.000.81%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.02M | -8.32M | -14.42M | -14.32M | -4.73M |
| Total Depreciation and Amortization | 667.30K | 667.30K | 667.30K | 667.30K | 837.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -711.70K | 1.06M | 9.00M | 9.25M | -3.25M |
| Change in Net Operating Assets | 2.23M | 2.12M | 1.62M | 1.80M | 1.31M |
| Cash from Operations | -4.84M | -4.47M | -3.13M | -2.60M | -5.83M |
| Capital Expenditure | -5.40K | -24.50K | -24.50K | -24.50K | -19.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.40K | -24.50K | -24.50K | -24.50K | -19.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | -374.20K |
| Issuance of Common Stock | 8.71M | 8.71M | 8.71M | -- | 0.00 |
| Repurchase of Common Stock | -204.00K | -204.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -1.49M | -3.76M | -5.11M | -6.23M | -7.09M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -385.50K | -765.30K | -765.30K | -765.30K |
| Cash from Financing | 7.02M | 4.36M | 2.83M | -7.00M | -8.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.18M | -138.50K | -323.80K | -9.63M | -14.08M |